Investor AB’s Bristol-Myers Squibb BMY Stock Holding History

Investor AB’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,975	Closed	-$232K	–	15
2016 Q4	$232K	Sell	3,975 -19,025	-83%	-$1.04M	0.02%	11
2016 Q3	$1.24M	Buy	+23,000	New	+$1.48M	0.09%	10

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investor AB's BMY Position: Q1 2017 in Review

Investor AB sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 3,975 shares — an estimated $232K sold.

Investor AB first reported a position in BMY in Q3 2016 and held it in 2 quarters. The position peaked at $1.24M in Q3 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Investor AB reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
Investor AB sold 3,975 Bristol-Myers Squibb shares in Q1 2017, an estimated $232K.
Investor AB first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 2 quarters.
Investor AB's Bristol-Myers Squibb position peaked at $1.24M in Q3 2016.
1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Investor AB's 13F filing for Q1 2017, filed 15 May 2017.